FOXO TECHNOLOGIES INC. (FOXO) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $142.00; Additional Paid in CapitalUSD $219.08M; Retained Earnings (Accumulated Deficit)USD $-218.09M; Stockholders' Equity Attributable to ParentUSD $988.31K.
- 2026-03-31: Common Stock, Value, IssuedUSD $373.27K; Additional Paid in CapitalUSD $235.43M; Retained Earnings (Accumulated Deficit)USD $-226.10M; Stockholders' Equity Attributable to ParentUSD $9.71M.
- 2025-12-31: Common Stock, Value, IssuedUSD $83.00; Additional Paid in CapitalUSD $235.79M; Retained Earnings (Accumulated Deficit)USD $-224.64M; Stockholders' Equity Attributable to ParentUSD $11.14M.
- 2025-09-30: Common Stock, Value, IssuedUSD $10.89K; Additional Paid in CapitalUSD $226.45M; Retained Earnings (Accumulated Deficit)USD $-206.26M; Stockholders' Equity Attributable to ParentUSD $20.20M.
FOXO TECHNOLOGIES INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Noncontrolling Interest, Increase from Business Combination USD | Treasury Stock, Common, Shares shares | Treasury Stock, Preferred, Shares shares | Treasury Stock, Shares, Retired shares | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares | APIC, Share-based Payment Arrangement, Recognition and Exercise USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $142.00 | $219.08M | $-218.09M | $988.31K | $913.22K | (m) | (m) | (m) | 3 month · $71.53K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $373.27K | $235.43M | $-226.10M | $9.71M | $9.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $83.00 | $235.79M | $-224.64M | $11.14M | $11.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $10.89K | $226.45M | $-206.26M | $20.20M | $20.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $1.13K | $205.85M | $-192.12M | $13.74M | $13.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $173.00 | $201.04M | $-191.33M | $9.71M | $9.65M | (m) | 3 month · $68.22K | 3 month · $172.12K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $119.00 | $195.86M | $-190.54M | $5.32M | $5.27M | (m) | (m) | 12 month · $61.91K | (m) | 12 month · $37.37K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-16 | (m) | (m) | (m) | (m) | $-4.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $1.00K | $166.22M | $-183.73M | $-17.51M | $-17.55M | (m) | 3 month · $24.45K | 3 month · $1.85K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $1.00K | $165.56M | $-181.69M | $-16.13M | $-16.17M | (m) | (m) | 3 month · $42.78K | (m) | 3 month · $37.37K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $1.00K | $164.28M | $-179.22M | $-14.94M | $-14.94M | (m) | (m) | 3 month · $17.15K | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $103.00K | (m) | (m) | (m) |
| 2023-12-31 | $765.00 | $162.96M | $-177.06M | $-14.10M | $-14.10M | 12 month · $21.00 | (m) | 12 month · $12.17K | (m) | (m) | 0.00 | (m) | (m) | (m) | (m) | (m) | 12 month · $-269.00K | (m) |
| 2023-09-30 | $6.00K | $162.09M | $-173.20M | $-11.10M | (m) | (m) | (m) | (m) | (m) | (m) | 0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-19 | $234.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $5.00K | $161.59M | $-168.63M | $-7.03M | $-7.03M | (m) | (m) | (m) | (m) | (m) | 0.00 | (m) | 6 month · 80.00K | (m) | (m) | (m) | 3 month · $772.00K 6 month · $1.67M | (m) |
| 2023-03-31 | (m) | $154.84M | $-154.87M | $-30.00K | (m) | (m) | (m) | (m) | (m) | (m) | 2.14M | (m) | (m) | (m) | 3 month · $901.00K | 3 month · 80.00K | (m) | (m) |
| 2022-12-31 | $3.00K | $153.94M | $-147.23M | $6.71M | $6.71M | (m) | (m) | (m) | (m) | (m) | 214.08K | (m) | (m) | (m) | 12 month · $716.00K | (m) | 12 month · $10.36M | 2.14M |
| 2022-09-30 | $3.00K | $144.67M | $-128.91M | $15.77M | (m) | (m) | (m) | 9 month · $507.00K | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $211.00K 9 month · $717.00K | (m) | (m) | (m) |
| 2022-06-30 | $63.00 | (m) | $-8.46M | $-54.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.65M | (m) | (m) | (m) | (m) | 3 month · $255.00K 6 month · $506.00K | (m) |
| 2022-03-31 | $63.00 | (m) | $-12.00M | $-37.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.65M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $63.00 | $4.90M | $-51.98M | $-25.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.65M | (m) | 12 month · $13.00K | (m) | (m) | (m) | (m) |
| 2021-09-30 | $63.00 | (m) | $-12.71M | $-24.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4.65M | (m) | 9 month · $13.00K | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $-13.08M | $1.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | $-11.21M | $-11.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $63.00 | $5.04M | $-16.19M | $8.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | $25.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | $25.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |